Follow the ディーブイエックス株式会社 share price and the full directors' dealings record of the company, a publicly traded company based in Japan. Shares trade on the JP market, under the supervision of EDINET (Japan FSA). Operating in the Health Care sector, ディーブイエックス株式会社 has recorded 20 reports. Market capitalisation: €10bn. The latest transaction was filed on 24 March 2026 (Holding update). Among the most active insiders: Hikari Tsushin K.K.. Every trade is accessible without an account.
20
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
19Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 19,273 of 29,053 companies
41.1
score / 100
Value
40
Quality
42
FCF yld-18%
Earn yld2.3%
EV/EBITDA9.3x
ROE2.5%
Gross mgn9.6%
Net mgn0.4%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
DVX Corporation es una empresa que cotiza en el mercado XTKS, especializada en el sector de la salud y farmacéutico. Se centra en el desarrollo y la comercialización de productos farmacéuticos innovadores.